 NEWTON, Mass., Jan. 29, 2021 PRNewswire -- Karyopharm Therapeutics Inc. Nasdaq:KPTI, a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has adopted a... 